$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Jim Cramer Says These 2 Large Cap Dividend Stocks Are Hot February Buys
01:35pm, Tuesday, 11'th Feb 2025
Media personality Jim Cramer often makes bold statements about companies and a lot of times, he proves himself correct.
An Investigation Has Commenced on Behalf of Merck & Co., Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MRK Losses.
07:25am, Tuesday, 11'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viol
Merck: 4 No-Brainer Reasons to Buy This Dip
11:30am, Monday, 10'th Feb 2025
Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the market can be unforgiving when companies even slightly miss expectations or f
ATTENTION Merck & Co., Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
07:30am, Monday, 10'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viol
Better High-Yield Dividend Stock: Pfizer vs. Merck
04:29am, Monday, 10'th Feb 2025
Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical industry. At recent prices, you can buy shares of Merck (MRK -0.88%) that of
One 'Safer' Buy In 10 February Dogs Of The Dow
07:54am, Saturday, 08'th Feb 2025
Verizon is the only Dow Dog meeting the ideal of dividends from $1K invested exceeding single share price, supported by adequate free cash flow. Analysts project net gains of 15.23% to 33.94% for the
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?
05:22pm, Friday, 07'th Feb 2025
Merck & Co . (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name drugs such as Keytruda, and the myriad of commercials the company shows on p
Merck & Co., Inc. (MRK) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
07:25am, Friday, 07'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viola
Investors who lost money on Merck & Co., Inc. should contact Levi & Korsinsky about an ongoing investigation - MRK
07:25am, Thursday, 06'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viola
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial e
Merck: Don't Fight The Tape, How Low Can It Go?
05:28pm, Wednesday, 05'th Feb 2025
Despite Merck & Co., Inc.'s strong fundamentals and promising pipeline, current negative sentiment suggests avoiding the stock until it stabilizes and shows signs of recovery. Merck's stock is underva
Why Merck (MRK) is a Top Dividend Stock for Your Portfolio
12:45pm, Wednesday, 05'th Feb 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes?
Should You Pick MRK Stock At $90?
11:14am, Wednesday, 05'th Feb 2025
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per share, c
Final Trade: SNAP, PYPL, SPYV, MRK
06:25pm, Tuesday, 04'th Feb 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Merck & Co., Inc. (MRK) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
04:30pm, Tuesday, 04'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viola
Sign In
Buy MRK